Skip to main content
. 2021 May 26;14(8):811–822. doi: 10.1158/1940-6207.CAPR-20-0620

Figure 3.

Figure 3. Incremental outcomes by sex for screening start age based on risk-stratification using the Total Risk + Sex score, compared with screening start age of 60 for the entire population. Incremental net monetary benefit is based on a cost-effectiveness threshold of £20,000/QALY. A: Net Monetary Benefit, B: Use of screening colonoscopies, C: CRC incidence, D: CRC mortality.

Incremental outcomes by sex for screening start age based on risk-stratification using the Total Risk + Sex score, compared with screening start age of 60 for the entire population. Incremental net monetary benefit is based on a cost-effectiveness threshold of £20,000/QALY. A: Net Monetary Benefit, B: Use of screening colonoscopies, C: CRC incidence, D: CRC mortality.